Loading…

Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine

Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleot...

Full description

Saved in:
Bibliographic Details
Published in:Medical Journal of Babylon 2021-04, Vol.18 (2), p.74-79
Main Author: Ali, Nidal Abu al-Qadir Muhammad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3070-183c0517b8eeefa3181a766f20422e25c30897f41ec50d41d73ab307ae49ab793
container_end_page 79
container_issue 2
container_start_page 74
container_title Medical Journal of Babylon
container_volume 18
creator Ali, Nidal Abu al-Qadir Muhammad
description Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior
doi_str_mv 10.4103/MJBL.MJBL_71_20
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6cf062a9c7124b91b27b6ab6de313260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A667528874</galeid><doaj_id>oai_doaj_org_article_6cf062a9c7124b91b27b6ab6de313260</doaj_id><sourcerecordid>A667528874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3070-183c0517b8eeefa3181a766f20422e25c30897f41ec50d41d73ab307ae49ab793</originalsourceid><addsrcrecordid>eNptkcuKFDEUhgtxwGactTspcDvVk0tVUrUcGy8jPZeFgrtwKjkpM1QnTZIBe6eP4Iv4ED6KT2KmW2YQJJCc_Pzfz0lOVb2gZNlSws8uP7xeL-83Jali5Em1YJyyRkhBnlYL2peaduLzs-okpVtCCOs7UcRF9f0mhow6u-BrmMD5lOst6Nll-Irz728_nDd3Gk39ZbfFCPOEyUEN3tQwz8HsfLmNu3obNjhF8JCxTljswc2n9dWdnjE0q8ub2oaY8dfP0z26LrkaonfZeXxeHVmYE578PY-rT2_ffFy9b9bX7y5W5-tGcyJJQ3uuSUfl2COiBV7eBFIIy0jLGLKuuPpB2pai7ohpqZEcxkICtgOMcuDH1cUh1wS4VdvoNhB3KoBTeyHESUHMrnSshLZEMBi0pKwdBzoyOQoYhUFOOROkZL06ZE1Q7M7bkCPojUtanQshO9b3si2u5X9cZRncOB08Wlf0f4CzA6BjSCmifWiTEnU_Z7Uf8eOcC_HyQGCxlW95BFjbEyn5H85Ap9Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><creator>Ali, Nidal Abu al-Qadir Muhammad</creator><creatorcontrib>Ali, Nidal Abu al-Qadir Muhammad</creatorcontrib><description>Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and LC.</description><identifier>ISSN: 1812-156X</identifier><identifier>EISSN: 2312-6760</identifier><identifier>DOI: 10.4103/MJBL.MJBL_71_20</identifier><language>eng</language><publisher>Babylon, Iraq: University of Babylon, College of Medicine</publisher><subject>allodynia ; Chemical properties ; Complications and side effects ; Essences and essential oils ; Health aspects ; hyperalgesia ; l-carnitine ; neuropathy ; nucleo-cmp forte ; Paclitaxel ; Pomegranate ; pomegranate seed oil ; الرمان ; باكليتاكسيل</subject><ispartof>Medical Journal of Babylon, 2021-04, Vol.18 (2), p.74-79</ispartof><rights>COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3070-183c0517b8eeefa3181a766f20422e25c30897f41ec50d41d73ab307ae49ab793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ali, Nidal Abu al-Qadir Muhammad</creatorcontrib><title>Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine</title><title>Medical Journal of Babylon</title><description>Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and LC.</description><subject>allodynia</subject><subject>Chemical properties</subject><subject>Complications and side effects</subject><subject>Essences and essential oils</subject><subject>Health aspects</subject><subject>hyperalgesia</subject><subject>l-carnitine</subject><subject>neuropathy</subject><subject>nucleo-cmp forte</subject><subject>Paclitaxel</subject><subject>Pomegranate</subject><subject>pomegranate seed oil</subject><subject>الرمان</subject><subject>باكليتاكسيل</subject><issn>1812-156X</issn><issn>2312-6760</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkcuKFDEUhgtxwGactTspcDvVk0tVUrUcGy8jPZeFgrtwKjkpM1QnTZIBe6eP4Iv4ED6KT2KmW2YQJJCc_Pzfz0lOVb2gZNlSws8uP7xeL-83Jali5Em1YJyyRkhBnlYL2peaduLzs-okpVtCCOs7UcRF9f0mhow6u-BrmMD5lOst6Nll-Irz728_nDd3Gk39ZbfFCPOEyUEN3tQwz8HsfLmNu3obNjhF8JCxTljswc2n9dWdnjE0q8ub2oaY8dfP0z26LrkaonfZeXxeHVmYE578PY-rT2_ffFy9b9bX7y5W5-tGcyJJQ3uuSUfl2COiBV7eBFIIy0jLGLKuuPpB2pai7ohpqZEcxkICtgOMcuDH1cUh1wS4VdvoNhB3KoBTeyHESUHMrnSshLZEMBi0pKwdBzoyOQoYhUFOOROkZL06ZE1Q7M7bkCPojUtanQshO9b3si2u5X9cZRncOB08Wlf0f4CzA6BjSCmifWiTEnU_Z7Uf8eOcC_HyQGCxlW95BFjbEyn5H85Ap9Q</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Ali, Nidal Abu al-Qadir Muhammad</creator><general>University of Babylon, College of Medicine</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20210401</creationdate><title>Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine</title><author>Ali, Nidal Abu al-Qadir Muhammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3070-183c0517b8eeefa3181a766f20422e25c30897f41ec50d41d73ab307ae49ab793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>allodynia</topic><topic>Chemical properties</topic><topic>Complications and side effects</topic><topic>Essences and essential oils</topic><topic>Health aspects</topic><topic>hyperalgesia</topic><topic>l-carnitine</topic><topic>neuropathy</topic><topic>nucleo-cmp forte</topic><topic>Paclitaxel</topic><topic>Pomegranate</topic><topic>pomegranate seed oil</topic><topic>الرمان</topic><topic>باكليتاكسيل</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ali, Nidal Abu al-Qadir Muhammad</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>CrossRef</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Medical Journal of Babylon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ali, Nidal Abu al-Qadir Muhammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine</atitle><jtitle>Medical Journal of Babylon</jtitle><date>2021-04-01</date><risdate>2021</risdate><volume>18</volume><issue>2</issue><spage>74</spage><epage>79</epage><pages>74-79</pages><issn>1812-156X</issn><eissn>2312-6760</eissn><abstract>Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and Background: Hyperalgesia and allodynia are abnormal sensory signs which are usually seen along neuropathic pain (NP) in patients on paclitaxel (PT) chemotherapy. Pomegranate seed oil (PSO) has been used in the traditional medicine for the different kinds of pain. Nucleo‑CMP Forte® (NCF) is a nucleotide‑based drug and L‑carnitine (LC) is a member of natural compounds have been shown effective in diverse peripheral neuroglial disorders. The aim of this study is to compare the anti‑hyperalgesia and anti‑allodynia activity of PSO, NCF, and LC in PT‑induced neuropathy. Materials and Methods: Thirty adult male mice were divided equally into five groups of six mice in each group as follows: Control (C), PT, PSO (PTpso), NCF (PTn), and LC (PTc) groups. NP was induced by the administration of PT (6 mg/kg, i. p. , once weekly) to the mice in all groups except C group. PSO, NCF, and LC were administered orally once daily to mice with PT‑induced neuropathy in their corresponding groups. Different behavior parameters were used to test the anti‑hyperalgesic and anti‑allodynic effect of PSO, NCF, and LC on days 0, 7, 14, 21, and 28 of PT administration. Results: PSO, NCF, and LC significantly attenuated NP induced by PT from day 14 up to 28 days using the different behavioral tests for thermal hyperalgesia and allodynia. Conclusion: PSO, NCF, and LC have significant potential anti‑nociceptive and analgesic activity against PT‑induced NP and PSO was the most efficacious than NCF and LC.</abstract><cop>Babylon, Iraq</cop><pub>University of Babylon, College of Medicine</pub><doi>10.4103/MJBL.MJBL_71_20</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1812-156X
ispartof Medical Journal of Babylon, 2021-04, Vol.18 (2), p.74-79
issn 1812-156X
2312-6760
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6cf062a9c7124b91b27b6ab6de313260
source Medknow Open Access Medical Journals(OpenAccess)
subjects allodynia
Chemical properties
Complications and side effects
Essences and essential oils
Health aspects
hyperalgesia
l-carnitine
neuropathy
nucleo-cmp forte
Paclitaxel
Pomegranate
pomegranate seed oil
الرمان
باكليتاكسيل
title Protection against paclitaxel‑induced hyperalgesia and allodynia by pomegranate seed oil, Nucleo-CMP forte®, and L‑carnitine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20against%20paclitaxel%E2%80%91induced%20hyperalgesia%20and%20allodynia%20by%20pomegranate%20seed%20oil,%20Nucleo-CMP%20forte%C2%AE,%20and%20L%E2%80%91carnitine&rft.jtitle=Medical%20Journal%20of%20Babylon&rft.au=Ali,%20Nidal%20Abu%20al-Qadir%20Muhammad&rft.date=2021-04-01&rft.volume=18&rft.issue=2&rft.spage=74&rft.epage=79&rft.pages=74-79&rft.issn=1812-156X&rft.eissn=2312-6760&rft_id=info:doi/10.4103/MJBL.MJBL_71_20&rft_dat=%3Cgale_doaj_%3EA667528874%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3070-183c0517b8eeefa3181a766f20422e25c30897f41ec50d41d73ab307ae49ab793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A667528874&rfr_iscdi=true